Taysha Gene Therapies shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Octagon Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $30M | 9.1M | 3.27 |
| 2025-06-30 | $29M | 13M | 2.31 |
| 2025-03-31 | $15M | 11M | 1.39 |
| 2024-12-31 | $18M | 11M | 1.73 |
| 2024-09-30 | $9.2M | 4.6M | 2.01 |
| 2024-06-30 | $10M | 4.6M | 2.24 |
| 2024-03-31 | $8.7M | 3.0M | 2.87 |
| 2023-09-30 | $8.8M | 2.8M | 3.16 |
| 2021-06-30 | $6.8M | 320k | 21.20 |
| 2021-03-31 | $6.5M | 320k | 20.30 |
| 2020-12-31 | $8.5M | 320k | 26.54 |